Global Navigation
IMS Report on Bridging the gap between approval and access in UK oncology practice
FREE DOWNLOAD Date Published: 01 May 2007 Download size: 0.2MB
IMS Report on Bridging the gap between approval and access in UK oncology practice
- The signficant challenges in securing usage in protocols of care and how they affect market access.
- How the anticipated explosion of innovative anti-cancer therapeutics and technologies in the therapy pipeline provide can work for and against pharma.
- The stats and forecasts behind the issues.
- The health economics evaluations you need to prepare to demonstrate clear added value of your product.
- Understanding the NICE and SMC decision-making process and product placement in the private sector.
- How we can learn from the processes behind introduction of novel therapies for renal cancer.
DOWNLOAD THIS FREE GUIDE
IMS Report on Bridging the gap between approval and access in UK oncology practice
Please note:
These downloads are single copies for your personal use only as specified in our site terms and conditions.
If you are interested in buying bulk copies in either digital or print formats, or you would like to find out how PMLiVE and PMGroup could fulfil your business needs, please see our corporate site, send us a message – or call our sales team on +44 (0)1372 414200.
